"Yaquinus" (tofacitinib) is a drug,belonging to the group of selective immunosuppressants. Such means provide artificial suppression of immunity. They are indispensable in the treatment of pathologies of the immune system. So, to combat moderate or severe rheumatoid arthritis, which has an inadequate response to treatment with basic anti-inflammatory drugs, the drug "Yaquinus" is used.

Instructions for using this tool will be offered to your attention later in the article.

Where to buy the drug "Yaquinus" cheaper: the price

Patients with severe pathologies are forced to spendlarge funds for the purchase of necessary drugs. The tablets "Yaquinus" are not an exception. The price for them in the Russian Federation is kept at around 50,000 rubles, which can not but upset people who give all their strength to fight the disease.

Online WWW.ONKO24.COM The drug can be bought much cheaper by providing documents about the need for this treatment.

Dosage

This agent is manufactured in tablets whichapply orally, regardless of food intake. The recommended dose of the drug "Yaquinus" at the same time is 5 mg, twice a day. Accordingly, the patient's state may increase to 10 mg.

To some patients the dose is adjusted, depending on the laboratory parameters.

Contraindications

"Yaquinus" has contraindications for use:

• the drug is not used in patients with severe liver or kidney pathologies;
• for those infected with the hepatitis C virus and / or B;
• in severe infections, including local infections;
• during pregnancy and feeding;
• under the age of 18 years.

During treatment with this tool, experts do not recommend the use of live vaccines, biological products and powerful immunosuppressants.

Side effects

As confirmed by the experts' responses to the Yaquinus preparation, the most frequent undesirable reactions to the use of this drug are:

• serious infections of the upper respiratory tract;
• herpes zoster;
• pneumonia;
• bronchitis;
• cystitis;
• pharyngitis;
• flu.

Also, patients can complain of headache, diarrhea, increased blood pressure, anemia, dyspnoea, skin rash.

Special instructions for the use of tablets "Yaquinus": instruction

To avoid undesirable consequences from the application of the described means, it is necessary to adhere to certain recommendations:

1. Before applying the drug to a patient with a chronic infection or predisposed to its development, and also after contact with patients with tuberculosis, it is necessary to evaluate the relationship between benefit and risk.
2. When a new infection occurs during the application of the "Yaquinus" tablets, a rapid and complete diagnostic examination, similar to that performed in patients with immunodeficiency, should be performed.
3. The drug should be taken with cautionpatients who have a risk of gastrointestinal perforation. Those who developed symptoms on the background of taking this remedy should be immediately examined to identify early signs of pathology.